• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cedara results boom as new CFO named

Article

On the financial ropes less than two years ago, Cedara Software is fighting back. The company achieved a 50% boost in revenues in the three months ended March 31 to $13.5 million compared with $9 million in the third quarter of 2003. Net income for the

On the financial ropes less than two years ago, Cedara Software is fighting back. The company achieved a 50% boost in revenues in the three months ended March 31 to $13.5 million compared with $9 million in the third quarter of 2003. Net income for the quarter was $5.1 million, compared with a net loss of $1.6 million in 3Q the previous year. Contributing heavily to the company's improved financial picture were three major agreements Cedara struck with OEMs. Revenues from one of these were recognized in the recent third quarter. Substantial revenues from the other two are likely to be recognized next quarter. In reporting the financial results, Cedara announced the appointment of Brian Pedlar as chief financial officer. He previously served as Cedara's director of finance and administration.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.